Adherence and decision AIDS: a model and a narrative review
- PMID: 20519453
- DOI: 10.1177/0272989X10370487
Adherence and decision AIDS: a model and a narrative review
Abstract
Background: Patient adherence to medication or lifestyle interventions is a serious concern. Interventions to improve adherence exist, but their effects are usually small. Several authors suggested that decision aids may positively affect adherence.
Objective: . This presentation examines the role of decision aids in adherence research through development of a model and a narrative review.
Methods: and
Results: . I: A model was developed to organize pathways relating decision aids and adherence. There is clinical evidence for these pathways, suggesting that decision aids may potentially improve adherence. The model is helpful when considering measures to study decision aids and adherence. II: A narrative review of decision aids and adherence was done. A systematic search resulted in 11 randomized studies. Two studies, both in the hypertension management domain, were positive. Shortcomings were identified regarding the range of adherence measures, the sample size, and the
Study design: It is argued that outcomes for the option "nonadherent" behavior should be described explicitly in the decision aid to inform patients about the costs and benefits of nonadherent behavior.
Conclusions: . A relation between decision aids and adherence is plausible in view of the psychological and medical literature. A systematic search showed that experimental evidence relating decision aids and adherence is inconclusive. Rigorous trials on this topic are worthwhile. Such trials should employ adequate sample sizes, multiple adherence measures, and a control arm delivering usual care. The decision aid should describe the option "being nonadherent" and its outcomes.
Similar articles
-
Physician-patient communication as a tool that can change adherence.Ann Allergy Asthma Immunol. 2009 Jul;103(1):1-2. doi: 10.1016/S1081-1206(10)60134-2. Ann Allergy Asthma Immunol. 2009. PMID: 19663119 No abstract available.
-
What information do patients need to make a medical decision?Med Decis Making. 2010 Sep-Oct;30(5 Suppl):11S-13S. doi: 10.1177/0272989X10381349. Med Decis Making. 2010. PMID: 20881150 No abstract available.
-
The origins of the DECISIONS survey.Med Decis Making. 2010 Sep-Oct;30(5 Suppl):17S-19S. doi: 10.1177/0272989X10381874. Med Decis Making. 2010. PMID: 20881152 No abstract available.
-
Patient adherence to medication requirements for therapy of type 2 diabetes.Int J Clin Pract. 2011 Mar;65(3):314-22. doi: 10.1111/j.1742-1241.2010.02544.x. Int J Clin Pract. 2011. PMID: 21314869 Review.
-
Patient-centered communication to assess and enhance patient adherence to glaucoma medication.Ophthalmology. 2009 Nov;116(11 Suppl):S37-42. doi: 10.1016/j.ophtha.2009.06.023. Ophthalmology. 2009. PMID: 19837259 Review.
Cited by
-
Adherence to anti-retroviral therapy, decisional conflicts, and health-related quality of life among treatment-naïve individuals living with HIV: a DEARS-J observational study.J Pharm Health Care Sci. 2023 Mar 2;9(1):9. doi: 10.1186/s40780-023-00277-y. J Pharm Health Care Sci. 2023. PMID: 36859482 Free PMC article.
-
Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosis.Mult Scler J Exp Transl Clin. 2021 Jul 15;7(3):20552173211029966. doi: 10.1177/20552173211029966. eCollection 2021 Jul-Sep. Mult Scler J Exp Transl Clin. 2021. PMID: 34350027 Free PMC article.
-
Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development.BMC Med Inform Decis Mak. 2021 Apr 9;21(1):123. doi: 10.1186/s12911-021-01479-w. BMC Med Inform Decis Mak. 2021. PMID: 33836742 Free PMC article.
-
Effects of decision aids for depression treatment in adults: systematic review.BJPsych Bull. 2022 Feb;46(1):42-51. doi: 10.1192/bjb.2020.130. BJPsych Bull. 2022. PMID: 33371926 Free PMC article. Review.
-
Exploring the Cost Effectiveness of Shared Decision Making for Choosing between Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis in the Netherlands: A State Transition Model.Med Decis Making. 2020 Nov;40(8):1003-1019. doi: 10.1177/0272989X20961091. Med Decis Making. 2020. PMID: 33174513 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
